These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 16979616

  • 1. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer.
    Boer K, Deufel T, Schmidt D, Streck S, Kiehntopf M.
    Clin Biochem; 2006 Oct; 39(10):1041-3. PubMed ID: 16979616
    [Abstract] [Full Text] [Related]

  • 2. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer.
    LeGatt DF, Shalapay CE, Cheng SB.
    Clin Biochem; 2004 Nov; 37(11):1022-30. PubMed ID: 15498532
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods.
    De BK, Jimenez E, De S, Sawyer JC, McMillin GA.
    Clin Chim Acta; 2009 Dec; 410(1-2):25-30. PubMed ID: 19751714
    [Abstract] [Full Text] [Related]

  • 6. Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer.
    Griffey MA, Hock KG, Kilgore DC, Wei TQ, Duh SH, Christenson R, Scott MG.
    Clin Chim Acta; 2007 Sep; 384(1-2):48-51. PubMed ID: 17588555
    [Abstract] [Full Text] [Related]

  • 7. The Abbott Architect c8000: analytical performance and productivity characteristics of a new analyzer applied to general chemistry testing.
    Pauli D, Seyfarth M, Dibbelt L.
    Clin Lab; 2005 Sep; 51(1-2):31-41. PubMed ID: 15719702
    [Abstract] [Full Text] [Related]

  • 8. A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood.
    Salm P, Taylor PJ, Rooney F.
    Ther Drug Monit; 2008 Jun; 30(3):292-300. PubMed ID: 18520600
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F, Debord J, Parant F, Labalette M, Kamar N, Rostaing L, Rousseau A, Marquet P.
    Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
    Johnson-Davis KL, De S, Jimenez E, McMillin GA, De BK.
    Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
    [Abstract] [Full Text] [Related]

  • 15. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA, Dijkers EC, Uges DR.
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique.
    Ansermot N, Fathi M, Veuthey JL, Desmeules J, Rudaz S, Hochstrasser D.
    Clin Biochem; 2008 Jul; 41(10-11):910-3. PubMed ID: 18358833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL, Wang XD, Wang CX, Fu Q, Liu LS, Huang M, Zhou SF.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May 01; 867(1):111-8. PubMed ID: 18417431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.